ASDS

Over 130 Resident Dermatologists Receive In-Depth Cosmetic Training From Renowned ASDS Member Physicians

Retrieved on: 
Mittwoch, Mai 22, 2024
Faculty, Peel (fruit), Area studies, Treatment, ASDS, Curriculum, Q&A, Forensic facial reconstruction, La Roche-Posay, Needle, Nursing

Career Paths

Key Points: 
  • Career Paths
    The course agenda is purposefully scheduled with dedicated time for networking breaks and visiting industry partners in the exhibit area.
  • Additionally, residents enjoyed a welcome reception on Friday evening to mingle with the renowned faculty and industry supporters, as well as a carnival-themed reception hosted by La Roche-Posay on Saturday.
  • This was a fantastic learning opportunity, especially for upper-level residents who have had some hands-on experience and have thus had the opportunity to generate questions.
  • Another echoed, “The current curriculum at my home program has minimal exposure to cosmetic procedures, yet they are required for examination purposes.

ASDS/A Board of Directors Appoints Tara Azzano as Executive Director

Retrieved on: 
Montag, April 8, 2024
Research, Diagnosis, Executive, Patient, Association management, FRCPC, Society, Interim, Meeting, ASDS, Medicine, Management

Schaumburg, IL, April 08, 2024 (GLOBE NEWSWIRE) -- Tara L. Azzano was recently named Executive Director of the American Society for Dermatologic Surgery (ASDS), the largest specialty organization in the U.S. exclusively representing dermatologic surgeons.

Key Points: 
  • Schaumburg, IL, April 08, 2024 (GLOBE NEWSWIRE) -- Tara L. Azzano was recently named Executive Director of the American Society for Dermatologic Surgery (ASDS), the largest specialty organization in the U.S. exclusively representing dermatologic surgeons.
  • She joined the organization in 2002 as the Director of Education, Research and Meetings.
  • Azzano has almost a quarter of a century’s worth of experience with ASDS/A, and her institutional knowledge of our Society is unprecedented.
  • “I am truly thrilled to have been chosen as the next Executive Director and to continue to share my passion for dermatologic surgery.

Skin Expert Dr. Martha Viera Joins Exclusive Haute Beauty Network

Retrieved on: 
Samstag, Februar 17, 2024
UCV, Beauty, ISD, MD, Friends, International Society, General surgery, Life, University, AAD, Central University of Venezuela, Resident, Organization, ASDS, Family, Medicine, Patient, WDS, Publication, American Academy

NEW YORK, Feb. 17, 2024 /PRNewswire-PRWeb/ -- Martha Viera, MD, is a talented dermatologist and cutaneous surgeon at Martha Viera Dermatology in Coral Gables, Florida.

Key Points: 
  • Dr. Martha Viera joins Haute Beauty Network as a skin expert representing the Coral Gables, FL market.
  • NEW YORK, Feb. 17, 2024 /PRNewswire-PRWeb/ -- Martha Viera, MD, is a talented dermatologist and cutaneous surgeon at Martha Viera Dermatology in Coral Gables, Florida.
  • Born in Caracas, Venezuela, Dr. Viera completed medical school in 2001 at Universidad Central de Venezuela (UCV) in Caracas.
  • In her personal life, Dr. Viera is a mother of two boys, and they enjoy a healthy, active, and balanced lifestyle.

Seth L. Matarasso, MD, Begins ASDS / ASDSA Presidency

Retrieved on: 
Montag, November 27, 2023
Mentorship, Treasurer, Policy, Baylor College of Medicine, Archive, Physician, ASDS, Hope, Evidence-based medicine, Strategic planning, MD, Society, Samuel, American Academy, University, Human, Mount Sinai School, Publication, Journal, Strategy, Clinical professor, Communication

Reimagining the future by fostering member engagement in and proactively reinforcing patient safety with those in a position to determine policy on the practice of medicine.

Key Points: 
  • Reimagining the future by fostering member engagement in and proactively reinforcing patient safety with those in a position to determine policy on the practice of medicine.
  • Embracing change and hope by implementing a new strategic plan and confirming a new Executive Director.
  • Enhancing and evolving members’ unified communication as credible medical sources, educating the public, medical peers and legislators on the scope of dermatologic surgeons’ expertise.
  • “To serve as the President of the ASDS and ASDSA is one of the most significant honors of my professional career; it is humbling and a privilege,” said Dr. Matarasso during his first presidential address.

Castle Biosciences Announces Multiple Data Presentations at the 2023 American Society for Dermatologic Surgery Annual Meeting

Retrieved on: 
Dienstag, November 14, 2023
Mental Health, Medical Supplies, Genetics, Clinical Trials, Biotechnology, Health, Pharmaceutical, General Health, Oncology, Research, Annual general meeting, NCCN, ART, Lymph node, National Comprehensive Cancer Network, Risk, ASDS, Patient, BWH, SLN, SCC, Abstract, MPH, Diagnosis, University, Medicare, Society, Summary, GEP, Metastasis, T2A, Pharmaceutical industry, Medical imaging, Brigham

Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that data spanning its dermatologic portfolio of gene expression profile (GEP) tests was recently presented at the 2023 American Society for Dermatologic Surgery (ASDS) Annual Meeting in Chicago.

Key Points: 
  • Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that data spanning its dermatologic portfolio of gene expression profile (GEP) tests was recently presented at the 2023 American Society for Dermatologic Surgery (ASDS) Annual Meeting in Chicago.
  • “The robust data presented at ASDS underscores the value of GEP testing across multiple skin cancer indications” said Robert Cook, Ph.D., senior vice president of research and development at Castle Biosciences.
  • Summary: ART is recommended based on high-risk clinicopathologic features of SCC, but these criteria are wide-ranging, encompassing a broad range of patients.
  • Additionally, a DecisionDx-SCC Class 2B result was the only risk factor that successfully identified patients who would benefit from ART.

Turn Biotechnologies First to Deliver mRNA into the Dermis Using Proprietary LNPs, with No Distribution to Other Organs

Retrieved on: 
Dienstag, November 7, 2023
Therapy, Spleen, ASDS, Liver, Skin, Research, Society, Fibroblast, Transfection, Tissue, Lipid, Messenger, Safety, Gene expression, Vaccine, Veterinary medicine, Dermatology

The company used its eTurna lipid nanoparticle delivery platform to precisely reach in vivo dermal fibroblasts with an mRNA formulation.

Key Points: 
  • The company used its eTurna lipid nanoparticle delivery platform to precisely reach in vivo dermal fibroblasts with an mRNA formulation.
  • The eTurna-delivered formulation remained localized in the injection site and did not distribute to other organs.
  • Turn Bio's most recent research was shared at the American Society for Dermatologic Surgery Annual Meeting held Nov. 2-5 in Chicago.
  • "It shows promise to significantly expand the therapies dermatologists can provide – and dramatically improve the quality of our patients' lives."

Turn Biotechnologies First to Deliver mRNA into the Dermis Using Proprietary LNPs, With No Distribution to Other Organs

Retrieved on: 
Dienstag, November 7, 2023
Therapy, Spleen, ASDS, Liver, Skin, Research, Society, Fibroblast, Biotechnology, Transfection, Tissue, Lipid, Messenger, Safety, Gene expression, Vaccine, Veterinary medicine, Dermatology

The company used its eTurna lipid nanoparticle delivery platform to precisely reach in vivo dermal fibroblasts with an mRNA formulation.

Key Points: 
  • The company used its eTurna lipid nanoparticle delivery platform to precisely reach in vivo dermal fibroblasts with an mRNA formulation.
  • The eTurna-delivered formulation remained localized in the injection site and did not distribute to other organs.
  • Turn Bio's most recent research was shared at the American Society for Dermatologic Surgery Annual Meeting held Nov. 2-5 in Chicago.
  • "It shows promise to significantly expand the therapies dermatologists can provide – and dramatically improve the quality of our patients' lives."

Dermatologic Surgeons Recognized for Annual Awards at the 2023 ASDS Annual Meeting

Retrieved on: 
Dienstag, November 7, 2023
Education, Inflammation, International, Medicare, History, MBA, ASDS, Organization, Health, Research, Cryomodule, Systematic review, Meta-analysis, Lecture, Society, Tribhuvan University Teaching Hospital, Medicine, Reduction, Surgeon, Partnership, CAE, Samuel, Melanoma, Chester L. Krause Memorial Distinguished Service Award, Amputation, Associate, Veterinary medicine, Dentistry, Management, Nursing, Dermatology, MD, MBBS, Pain, DRS, Venereology

Schaumburg, IL, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Elite dermatologists were recognized during the American Society for Dermatologic Surgery (ASDS) Annual Meeting in Chicago, Illinois, for a variety of annual service awards, competitions and program recognitions.

Key Points: 
  • Schaumburg, IL, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Elite dermatologists were recognized during the American Society for Dermatologic Surgery (ASDS) Annual Meeting in Chicago, Illinois, for a variety of annual service awards, competitions and program recognitions.
  • The Society’s annual awards acknowledge their outstanding work and commitment to the dermatologic surgery specialty.
  • Dr. Butterwick was recognized at the 16th Annual ASDS Gala on Saturday, Nov. 4.
  • The 2023 grant recipients are:
    The ASDS Journal Awards Work Group reviews program applications to identify those that exceptionally evaluate existing works.

Newly Elected Dermatologic Surgeons to Begin Leadership Terms at the 2023 ASDS Annual Meeting

Retrieved on: 
Freitag, November 3, 2023
Intelligence, Policy, Education, Arizona State University, Food, Mayo Clinic Graduate School of Biomedical Sciences, Dermatology, Physician, ASDS, Legislation, Advertising, FRCPC, Health, Regulation of tobacco by the U.S. Food and Drug Administration, Master of Science, Society, Mohs, Practice, S-1 Executive Committee, Resident Representative, Environment, Resident, Medicine, Executive Committee, Internal medicine, Scope of practice, Safety, App, Patient, Patient safety, Dentistry, Medical device, Management, Nursing, Science, MD

Schaumburg, IL, Nov. 03, 2023 (GLOBE NEWSWIRE) -- The American Society for Dermatologic Surgery (ASDS) is pleased to announce its newly elected leaders, whose terms will begin following the Society’s Annual Membership Meeting on Friday, Nov. 3, led by ASDS/A President Vince Bertucci, MD, FRCPC.

Key Points: 
  • Schaumburg, IL, Nov. 03, 2023 (GLOBE NEWSWIRE) -- The American Society for Dermatologic Surgery (ASDS) is pleased to announce its newly elected leaders, whose terms will begin following the Society’s Annual Membership Meeting on Friday, Nov. 3, led by ASDS/A President Vince Bertucci, MD, FRCPC.
  • The individuals elected to serve the Society will also serve in the same position for the same tenure with the Society’s advocacy arm, American Society for Dermatologic Surgery Association (ASDSA).
  • Dr. Mariwalla will proceed in succession from Vice President to President-Elect and assume the role of President for the 2024-25 term.
  • Dr. Hooper will present the 2023 financial report at the Annual Membership Meeting and serve her final year as the Society’s Treasurer in 2023-24.

ASDSA Recognizes Its 2023 Top Advocates

Retrieved on: 
Donnerstag, November 2, 2023
Physician, ASDS, MD, Safety, FRCPC, Patient, Society, Veterinary medicine

Schaumburg, IL, Nov. 02, 2023 (GLOBE NEWSWIRE) -- The American Society for Dermatologic Surgery Association (ASDSA ) is pleased to announce its 2023 Top Advocates will be honored at the 2023 ASDS / ASDSA Annual Meeting .

Key Points: 
  • Schaumburg, IL, Nov. 02, 2023 (GLOBE NEWSWIRE) -- The American Society for Dermatologic Surgery Association (ASDSA ) is pleased to announce its 2023 Top Advocates will be honored at the 2023 ASDS / ASDSA Annual Meeting .
  • Top Advocates are chosen based on their contributions to ASDSA’s advocacy efforts throughout the year and demonstrated commitment to patient safety in the field of dermatologic surgery.
  • There are 11 physicians being acknowledged as ASDSA Top Advocates in 2023:
    “These dermatologic surgeons have shown incredible efforts to support the ASDSA advocacy agenda,” said ASDSA President Vince Bertucci, MD, FRCPC.
  • “The ASDSA Top Advocate Program was created to acknowledge members who proactively advance the mission of ASDSA on behalf of dermatologic surgeons and strengthen connections with policymakers.